SEX DIFFERENCES IN THE PERFORMANCE OF THE TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM) RISK SCORE

被引：0

作者：

El Helou, Michel Chedid ^{[1
]}

Gupta, Mohak ^{[1
]}

Hussain, Muzna ^{[1
]}

Abadie, Bryan ^{[1
]}

Hanna, Mazen A. ^{[1
]}

Tang, Wai Hong Wilson ^{[1
]}

Jaber, Wael A. ^{[1
]}

Collier, Patrick ^{[1
]}

Martyn, Trejeeve ^{[1
]}

机构：

[1] Cleveland Clin, Cleveland, OH USA

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1074-13

引用

页码：351 / 351

页数：1

共 50 条

[1] Race, Sex, and Ejection Fraction-Based Differences in Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Risk Prediction
El Helou, Michel Chedid
Gupta, Mohak
Hussain, Muzna
Hanna, Mazen
Blumer, Vanessa
William, Preethi
Desai, Milind Y.
Abadie, Bryan Q.
Ives, Lauren
Tang, W. H. Wilson
Jaber, Wael A.
Collier, Patrick
Martyn, Trejeeve
JOURNAL OF CLINICAL MEDICINE, 2024, 13 (20)
[2] A simple ATTR-CM score to identify transthyretin amyloid cardiomyopathy burden in HFpEF patients
Ye, Min
Liu, Xiao
Gu, Zhenbang
Sun, Junyi
Dong, Yugang
Chen, Yili
Liu, Chen
Wu, Zexuan
Zhu, Wengen
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2023,
[3] PREVALENCE OF TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM) IN UNDIFFERENTIATED HFPEF
Healy, Liam
Mahon, Niall
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 733 - 733
[4] PREVALENCE OF TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM) IN UNDIFFERENTIATED HFPEF
Healy, L.
Giblin, G.
O'Sullivan, D.
Kavanagh, E.
Howley, E.
Tracey, C.
O'Neill, J.
Joyce, E.
O'Connell, M.
McDaid, A.
Clarke, A.
Gray, A.
Mahon, N.
HEART, 2022, 108 : A11 - A11
[5] Validation of the ATTR-CM score for transthyretin amyloid cardiomiopathy in a mediterranean cohort of patients at risk
Cediel, G.
Santesmases, J.
Domingo, M.
Moragas, G.
Sola, M.
Garcia-Calvo, X.
Guix, G.
Pacho, C.
Santiago-Vacas, E.
Borrellas, A.
Codina, P.
Figuerola, N.
Ruiz-Cueto, M.
Lupon, J.
Bayes-Genis, A.
EUROPEAN HEART JOURNAL, 2023, 44
[6] Practical guidelines for the diagnosis and treatment of transthyretin amyloid cardiomyopathy (ATTR-CM or transthyretin cardiac amyloidosis)
Tereshchenko, Sergey N.
Zhirov, Igor, V
Moiseeva, Olga M.
Adasheva, Tatiana, V
Ansheles, Alexey A.
Barbarash, Olga L.
Galyavich, Albert S.
Gudkova, Alexandra Ja
Zateyshchikov, Dmitry A.
Kostareva, Anna A.
Nasonova, Svetlana N.
Nedogoda, Sergey, V
Pecherina, Tamara B.
Ryzhkova, Daria, V
Sergienko, Vladimir B.
TERAPEVTICHESKII ARKHIV, 2022, 94 (04) : 584 - 595
[7] Clinical characteristics of patients with hereditary transthyretin amyloid cardiomyopathy (ATTR-CM) in Sarawak
Chen, L. S.
Oon, Y. Y.
Chung, B. K.
Thien, L. K.
Chow, H. B.
Pang, I. X.
Ling, H. S.
Chandan, D. B.
Tan, C. T.
Koh, K. T.
Said, A.
Cham, Y. L.
Alan, A. Y. Y.
Ong, T. K.
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 345 : 4 - 5
[8] Indication and electrical performance of conventional, resynchronisation and conduction system pacing in Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Dobner, Stephan
Tawo, Serlha
Wieser, Fabian
Graeni, Christoph
Haeberlin, Andreas
CIRCULATION, 2024, 150
[9] Suspecting and diagnosing transthyretin amyloid cardiomyopathy (ATTR-CM) in India: An Indian expert consensus
Mohan, Jagdish Chander
Dalal, Jamshed
Chopra, Vijay Kumar
Narasimhan, Calambur
Kerkar, Prafulla
Oomman, Abraham
Fcsi, Saumitra Ray
Sharma, Anshu Rajnish
Dougall, Pankaj
Simon, Shelley
Drm, Atul Verma
Radhakrishnan, Vivek
INDIAN HEART JOURNAL, 2022, 74 (06) : 441 - 449
[10] Clinical Burden of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in the USA From 2004 to 2022
Alexander, Kevin M.
Ersboell, Anne S.
Haase, Christiane L.
Mortensen, Julie T.
Maurer, Mathew S.
CIRCULATION, 2023, 148

← 1 2 3 4 5 →